Based on available data and mechanism of action, retatrutide appears most relevant for: People with significant obesity (BMI 35+) who want maximum weight reduction and haven't achieved their goals on semaglutide or tirzepatide People with type 2 diabetes who need both glycemic control and meaningful weight loss People who have plateaued on existing GLP-1 therapy and are wondering if a more powerful triple agonist would move the needle People focused on metabolic longevity , where reducing adiposity, improving insulin sensitivity, and lowering chronic inflammation are all high-priority goals If you're someone chasing a 5-10 lb cosmetic goal, retatrutide is probably overkill
All figures are from peer-reviewed trial publications
LifeRx.md: Your Partner in Weight Management At LifeRx.md, we are more than just a prescription service
Gondo et al, Growth Hormone-Releasing Peptide-2 Stimulates GH Secretion in GH-Deficient Patients with Mutated GH-Releasing Hormone Receptor, The Journal of Clinical Endocrinology & Metabolism, Volume 86, Issue 7, 1 July 2001, Pages 32793283, Mericq V, Cassorla F, Salazar T, Avila A, Iiguez G, Bowers CY, Merriam GR